$1.79
0.074.07%
At close: -
$1.73
-0.06-3.35%
After Hours: Jun 3, 6:13 PM EDT
Comments
Loading...
NeuroSense Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:NRSN | Benzinga
NeuroSense Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Apr 7
EPS
$-0.060
Quarterly Revenue
$0.00
Annual Revenue
(as of Dec 31)
(as of Dec 31)
–
Analyze the earnings history of NeuroSense Therapeutics using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| NRSN | NeuroSense Therapeutics | -$0.35 | — | — | — | $0.00 | — | — | — | 06/23/2025 | Get Alert |
| NRSN | NeuroSense Therapeutics | -$0.16 | — | -$0.06 | — | $0.00 | — | $0.00 | — | 04/07/2025 | Get Alert |
| NRSN | NeuroSense Therapeutics | $0.10 | -$0.16 | -$0.11 | 31.25% | $0.00 | — | $0.00 | — | 12/18/2024 | Get Alert |
| NRSN | NeuroSense Therapeutics | -$0.44 | -$0.20 | -$0.02 | 90.00% | $0.00 | — | $0.00 | — | 09/30/2024 | Get Alert |
| NRSN | NeuroSense Therapeutics | -$0.33 | -$0.20 | -$0.35 | -75.00% | $0.00 | — | $0.00 | — | 06/24/2024 | Get Alert |
| NRSN | NeuroSense Therapeutics | -$0.27 | -$0.23 | -$0.16 | 30.43% | $0.00 | — | $0.00 | — | 04/05/2024 | Get Alert |
| NRSN | NeuroSense Therapeutics | -$0.25 | — | $0.10 | — | $0.00 | — | $0.00 | — | 11/28/2023 | Get Alert |
| NRSN | NeuroSense Therapeutics | -$0.31 | — | -$0.44 | — | $0.00 | — | $0.00 | — | 08/16/2023 | Get Alert |
| NRSN | NeuroSense Therapeutics | -$0.24 | — | -$0.33 | — | $0.00 | — | $0.00 | — | 06/01/2023 | Get Alert |
| NRSN | NeuroSense Therapeutics | — | — | -$0.27 | — | — | — | $0.00 | — | 03/22/2023 | Get Alert |
| NRSN | NeuroSense Therapeutics | $0.93 | — | -$0.25 | — | $0.00 | — | $0.00 | — | 12/01/2022 | Get Alert |
| NRSN | NeuroSense Therapeutics | -$1.24 | — | -$0.31 | — | $0.00 | — | $0.00 | — | 08/31/2022 | Get Alert |
| NRSN | NeuroSense Therapeutics | -$0.38 | — | -$0.24 | — | $0.00 | — | $0.00 | — | 05/31/2022 | Get Alert |
NeuroSense Therapeutics (NRSN) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2024-12-18 | $-0.11 | $-0.16 | 31.3 % |
| Q2 | 2024-09-30 | $-0.02 | $-0.20 | 90.0 % |
| Q1 | 2024-06-24 | $-0.35 | $-0.20 | -75.0 % |
| Q4 | 2024-04-05 | $-0.16 | $-0.23 | 30.4 % |
NeuroSense Therapeutics (NRSN) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is NeuroSense Therapeutics (NASDAQ:NRSN) reporting earnings?
NeuroSense Therapeutics (NRSN) is scheduled to report earnings on June 23, 2025. The last reported earnings were for reported on April 7, 2025 for Q4.
What were the latest earnings per share (EPS) for NeuroSense Therapeutics (NASDAQ:NRSN)?
The Actual EPS was $-0.06, which missed the estimate of $0.00.
What were NeuroSense Therapeutics’s (NASDAQ:NRSN) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.
